高敏肌钙蛋白:急诊科追求急性冠脉综合征零漏诊率的西西弗斯式努力
本文综述了高敏肌钙蛋白(hsTn)检测在急诊科诊断急性冠脉综合征(ACS)及加速诊断方案中的应用证据。由于所研究的hsTn检测方法、delta肌钙蛋白检测时间间隔和研究人群存在异质性,文献的临床解读具有挑战性。hsTn的高敏感性依赖于医生能够临床判断患者疾病的验前概率低,医生可通过将阳性界值定义为检测限并利用delta肌钙蛋白检测来进一步确保最大敏感性。与标准肌钙蛋白检测相比,更高的敏感性以更低的特异性为代价, indiscriminate 检测可能导致非ACS综合征患者出现更多异常肌钙蛋白结果,潜在地导致医疗费用增加、住院增加、急诊停留时间延长和不必要的干预。
要点
- hsTn的高敏感性依赖于医生临床判断患者验前概率低,并可将阳性界值定义为检测限及利用delta肌钙蛋白检测以确保最大敏感性。
- 与标准肌钙蛋白检测相比,hsTn敏感性更高但特异性更低。
- indiscriminate 检测可能导致非ACS综合征患者出现更多异常肌钙蛋白结果,潜在地增加医疗费用、住院、急诊停留时间和不必要干预。
- 这些检测并不能免除对出院患者进行风险分层随访的必要性。
- 由于hsTn检测方法、delta肌钙蛋白检测时间间隔和研究人群存在异质性,文献的临床解读具有挑战性。
适用人群与场景
- 急诊科就诊的疑似急性冠脉综合征患者。
处置流程与药物剂量
- 医生可通过将阳性界值定义为检测限并利用delta肌钙蛋白检测来确保最大敏感性。
- 这些检测并不能免除对出院患者进行风险分层随访的必要性。
研究设计与关键结果
- 由于所研究的hsTn检测方法、delta肌钙蛋白检测时间间隔和研究人群存在异质性,文献的临床解读具有挑战性。
- hsTn的高敏感性依赖于医生能够临床判断患者疾病的验前概率低。
- 与标准肌钙蛋白检测相比,hsTn敏感性更高但特异性更低。
- indiscriminate 检测可能导致非ACS综合征患者出现更多异常肌钙蛋白结果,潜在地导致医疗费用增加、住院增加、急诊停留时间延长和不必要的干预。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 急诊医生应了解hsTn检测的潜力和局限性,掌握检测特征对于确保适当使用至关重要。
- hsTn检测不能免除对出院患者进行风险分层随访的必要性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The United States Food and Drug Administration recently approved a high sensitivity troponin (hsTn) assay for use. Recent literature has investigated the diagnostic accuracy of hsTn for acute coronary syndrome (ACS) in the emergency department (ED) and its use in accelerated diagnostic protocols.
OBJECTIVE: This article evaluates the existing literature and discusses incorporation of hsTn testing into ED clinical practice based on best available evidence.
DISCUSSION: Interpretation of this literature for clinical application is challenging due to heterogeneity across studies with regards to the hsTn assays examined, time intervals for delta troponin tests, and study populations. The high sensitivity of these assays is predicated upon the ability of the physician to clinically determine a patient to have a low pre-test probability of disease. Physicians may further ensure maximal sensitivity by defining the cut-off for a positive value as the limit of detection and utilizing delta troponin testing. These assays do not obviate the need to consider follow-up for risk stratification for discharged patients. Higher sensitivity compared to standard troponin tests comes at the expense of lower specificity. Indiscriminate testing may translate to greater numbers of abnormal troponin results in patients with non-ACS syndromes, potentially leading to increased healthcare costs, hospital admissions, increased ED lengths of stay, and unnecessary interventions.
CONCLUSION: As hsTn becomes more widespread, it is imperative emergency physicians understand its potential and limitations. Knowledge of test characteristics is vital to ensure appropriate use. Further study of hsTn is required to optimize use.
参考来源
- Summers SM, Long B, April MD, et al. High sensitivity troponin: The Sisyphean pursuit of zero percent miss rate for acute coronary syndrome in the ED. Am J Emerg Med. 2018. PMID: 29695327. doi:10.1016/j.ajem.2018.03.075
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。